Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- Prevalence of dyslipidemia in resource-limited settings is not well characterized
- Emerging data suggest that dyslipidemia and other metabolic toxicities are associated with HIV and ART in many developing countries[George 2009; Mutimura 2007; Manuthu 2008; Hiransuthikul 2007; Muyanja 2016; Nguyen 2016]
- Extreme poverty limits the ability of individuals to make choices about dietary intake and hinders healthy lifestyle patterns
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content